PPHM THE COMPANY THAT... well... read it for yourself:
TWST: Can you give us a realistic picture as to where you see Peregrine in the year 2005?
Mr. King: I see the company as hopefully having partnered Cotara to move that program forward. By then, I would hope that we could be nearing the completion of the Phase III clinical trial. The timing of that will be dependent on the partner. I view the company as really focusing its efforts on vascular targeting and the Vasopermeation Enhancement Agent programs. I view us as having strong clinical programs in both of those areas.
my favorite: PPHM THE COMPANY WITH NO EARNINGS AND $260M MARKET CAP WHOSE BOD MEMBERS EARN MORE THE MAJORITY OF MULTI-BILLION DOLLAR, INTERNATIONAL FORTUNE 500 CAMPANIES